Faculty - Cancer Prevention Ph.D. Track
Email: Richard.O'Connor@RoswellPark.org
| Faculty Member | Research Interest |
|---|---|
|
Christine Ambrosone, PhD, Senior Vice President, Population Sciences; Chair, Department of Cancer Prevention and Control |
Molecular epidemiology of cancer risk; breast cancer in African-American women; cancer treatment outcomes |
| AnneMarie W. Block, PhD, Laboratory Director, Cytogenetics Laboratory | Chromosome abnormalities in B-cell lymphoproliferative; mitogenic stimulation of human B cells; fluorescence in situ hybridization (FISH) |
| Paul Bogner, MD, Assistant Professor of Oncology Department of Pathology and Laboratory Medicine | Thoracic oncology, including the histological and molecular diagnosis, classification and staging of lung tumors, neoplastic and inflammatory dermatopathology |
|
Deborah O. Erwin, PhD, Director, Office of Cancer Health Disparities Research |
Development and testing of community-based interventions to address social determinants of inequities in cancer detection, treatment and access among minority and medically underserved populations. |
| Barbara Foster, PhD*, Associate Professor of Oncology, Department of Pharmacology and Experimental Therapeutics | Vitamin D analogs, selenium, dendritic cell vaccine, mechanisms of prostate cancer development |
| Theresa Hahn, PhD Professor of Oncology, Department of Medicine | Clinical epidemiology, outcomes research, evidence-based medicine; blood and marrow transplantation; and infectious disease epidemiology |
| Chi-Chen Hong, PhD, Associate Professor of Oncology, Department of Cancer Prevention and Control | The role of lifestyle-related factors on hormonal exposures and immune function in breast cancer survivors, impact of type 2 diabetes on cancer prognosis, thermal dysregulation among breast cancer patients. |
|
Assistant Professor of Oncology, Department of Cancer Pathology and Prevention Medical Psychologist, Department of Psychosocial Oncology |
Adjustment to breast cancer, survivorship, evaluation of the efficacy of palliative care treatment in alleviating physical and psychosocial symptoms |
| Andrew Hyland, PhD, Chair, Department of Health Behavior | Evaluating the impact of policies aimed at reducing the morbidity and mortality associated with the use of tobacco products |
| Surabhi Kakati, PhD, Assistant Research Director, Cytogenetics Laboratory | chromosomal abnormalities in leukemias, lymphomas and solid tumors |
|
Sue Leong, PhD, Emeritus Faculty, Department of Pathology and Laboratory Medicine |
New drug development, clinical trials, medical ethics, continuing medical education and immunology |
| Martin Mahoney, MD, PhD, Director, Cancer Prevention & Detection Center, Employee Health Clinic; Professor, Department of Cancer Prevention and Control | Cancer screening utilization and promotion; effect of Chernobyl-related radiation exposure on the risk of leukemia; smoking cessation |
| James R. Marshall, PhD, Distinguished Professor Emeritus | Selenium for chemoprevention, biomarkers to measure chemoprevention and molecular epidemiology |
| Patricia A. Masso-Welch, PhD, Adjunct Assistant Professor, Department of Cancer Prevention and Control | The impact of lifestyle interventions during developmental time points of rapid mammary gland remodeling (e.g., during puberty, post-lactational involution) on breast cancer risk and progression |
| Susan McCann, PhD, Professor of Oncology, Department of Cancer Prevention and Control | Nutritional and molecular epidemiology including the impact of diet on cancers of the reproductive organs |
| Philip McCarthy, MD, Professor of Oncology and Chief, Division of Blood and Marrow Transplantation, Department of Medicine | Health effects of radiation exposure, modulation of graft versus host disease and of chemotherapy toxicity, blood and marrow stem cell isolation, immune modulation after transplantation |
| Kirsten Moysich, PhD, Distinguished Professor of Oncology, Department of Cancer Prevention and Control | Ovarian cancer etiology and prognosis, immunosuppression, novel immune markers |
|
Professor of Oncology, Department of Cancer Prevention and Control Professor of Surgery, Department of Thoracic Surgery |
Lung cancer lymph node metastasis, disparities in lung cancer care, cancer control in resource-limited environments |
| Richard O’Connor, PhD, Professor of Oncology, Department of Health Behavior | Tobacco product regulation; tobacco harm reduction; development of unobtrusive and minimally invasive measures of tobacco exposure in humans |
| Mary Reid, PhD, Distinguished Professor of Oncology, Department of Medicine | Early detection and chemoprevention of lung and head and neck cancers; Biomarkers of exposure and risk for aerodigestive cancer |
| Laura Rusche, PhD, Assistant Professor, Department of Biological Sciences, University at Buffalo | |
| Sheila N. J. Sait, PhD, Research Director, Cytogenetics Laboratory | Double minute chromosomes (dms) and homogeneously staining regions (hsr) in leukemia and MDS |
| Gary J. Smith, PhD, Co-Leader, Prostate Program, Distinguished Professor, Oncology, Department of Urologic Oncology | Prevention and treatment of prostate cancer; prostatic stem cells, angiogenesis; racial differences in prostate cancer mortality. |
| Li Tang, PhD, Associate Professor of Oncology, Department of Cancer Prevention and Control | Molecular epidemiology, nutritional epidemiology and dietary intervention, chemoprevention, cancer survivorship |
| Maansi Bansal-Travers, PhD, Assistant Professor of Oncology, Department of Health Behavior |
Risk perceptions of tobacco and nicotine products; tobacco marketing, point-of-sale advertising, and counter marketing; tobacco packaging characteristics and health warning labels |
| Mark J. Travers, PhD, Assistant Professor of Oncology, Department of Health Behavior and Aerosol Pollution Exposure Research Laboratory (APERL). |
Tobacco smoke pollution exposure; evaluation of smokefree air and other tobacco control policies; new and emerging tobacco products. |
| Paul K. Wallace, PhD, Director of Flow Cytometry Laboratory | Flow cytometry, immunotherapy of cancer |
| Yue Wu, PhD, Assistant Professor of Oncology, Department of Urology |
Cancer prevention, cancer therapy, biology of prostate cancer |
| Song Yao, PhD, Associate Professor of Oncology,
Department of Cancer Prevention and Control |
Biological factors and related genetic variations in breast cancer etiology |
| Yuesheng Zhang, PhD, Professor of Oncology and Member, Department of Cancer Prevention and Control | Chemoprevention of bladder cancer, drug development in cancer prevention |
*Joint Appointment